Madrigal Pharmaceuticals inc. buy BiotechBee
Start price
30.09.22
/
50%
€66.50
Target price
31.12.24
€120.00
Performance (%)
324.36%
End price
05.05.23
€282.20
Summary
This prediction ended on 05.05.23 with a price of €282.20. The BUY prediction by BiotechBee for Madrigal Pharmaceuticals inc. saw massive gains of 324.36%. BiotechBee has a follow-up prediction for Madrigal Pharmaceuticals inc. where he still thinks Madrigal Pharmaceuticals inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Madrigal Pharmaceuticals inc. | 18.008% | 18.008% | -22.689% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to BiotechBee what are the pros and cons of Madrigal Pharmaceuticals inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Buy mit Kursziel 120,0
In the thread Trading Madrigal Pharmaceuticals inc.
Current prediction by BiotechBee for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€214.90
24.06.23
24.06.23
€380.00
31.05.26
31.05.26
-6.70%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
